Cargando…
Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitors
INTRODUCTION: Preclinical studies have demonstrated the ability of radiation therapy (RT) to augment immune response and tumor control by immune checkpoint inhibitors (ICI). However, numerous clinical trials combining RT and ICI have yielded relatively disappointing results. To improve understanding...
Autores principales: | Mundra, Vatsala, Yang, Yuqiu, von Itzstein, Mitchell S., Fattah, Farjana, Gonugunta, Amrit S., Hannan, Raquibul, Pop, Laurentiu M., Zhang, Yuanyuan, Wang, Yiqing, Sheffield, Thomas, Xie, Yang, Dowell, Jonathan E., Homsi, Jade, Rashdan, Sawsan, Park, Jason, Li, Quan-Zhen, Wakeland, Edward K., Gerber, David E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265517/ https://www.ncbi.nlm.nih.gov/pubmed/37285748 http://dx.doi.org/10.1016/j.tranon.2023.101689 |
Ejemplares similares
-
Humoral and cellular correlates of a novel immune-related adverse event and its treatment
por: Gonugunta, Amrit S, et al.
Publicado: (2021) -
Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors
por: von Itzstein, Mitchell S., et al.
Publicado: (2022) -
Correction to: Divergent prognostic effects of pre-existing and treatment-emergent thyroid dysfunction in patients treated with immune checkpoint inhibitors
por: von Itzstein, Mitchell S., et al.
Publicado: (2022) -
Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy
por: von Itzstein, Mitchell S., et al.
Publicado: (2022) -
Pseudoprogression in advanced non-small cell lung cancer treated with combination chemoimmunotherapy: a case report
por: Gonugunta, Amrit S., et al.
Publicado: (2022)